Anterior ischemic optic neuropathy in a patient with erectile dysfunction: Tadalafil as an offending medication
Erectile dysfunction (ED) has negative effects on quality of life. The first line of oral medication for this condition is phosphodiesterase type 5 inhibitors (PDE5I) including Tadalafil. Ocular complications associated with Tadalafil are rare and usually occurred in participant with known risk fact...
Saved in:
Main Authors: | Alireza Dehghani (Author), Mohammad-Hasan Ale (Author), Marjan Masjedi (Author), Arman Amirkhani (Author), Mohsen Pourazizi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tadalafil in the treatment of erectile dysfunction
by: Robert M Coward, et al.
Published: (2008) -
A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
by: Samuel L Washington III, et al.
Published: (2010) -
Tadalafil Once a Day for Men with Erectile Dysfunction: Is It Superior than On-Demand Administration?
by: Dimas Tri Prasetyo, et al.
Published: (2019) -
Evaluation of testosterone and prolactin hormones levels in erectile dysfunction patients after single oral dose of Tadalafil
by: Hayder Hamed Abed
Published: (2008) -
Regional and central hemodynamics in ischemic optic neuropathy
by: N.I. Khramenko, et al.
Published: (2018)